Registered number
13079984
AVIS PHARMALABS EXIM PRIVATE LIMITED
Filleted Accounts
30 November 2021
AVIS PHARMALABS EXIM PRIVATE LIMITED
Registered number: 13079984
Balance Sheet
as at 30 November 2021
Notes 2021
£
Current assets
Cash at bank and in hand 760
Creditors: amounts falling due within one year 3 (997)
Net current liabilities (237)
Net liabilities (237)
Capital and reserves
Share premium 3
Profit and loss account (240)
Shareholders' funds (237)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
V. PUROHIT
Director
Approved by the board on 29 August 2022
AVIS PHARMALABS EXIM PRIVATE LIMITED
Notes to the Accounts
for the period from 14 December 2020 to 30 November 2021
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
On March 2020, the World Health Organisation formally recognised COVID-19 as a pandemic. The implications of COVID-19 resulted in many governments across the world deciding to close down non-essential operations, which will have a great impact on the global economy.
At the date of approving the financial statements, due to the corrective action taken to reduce expenses and preserve cash, the pandemic has not resulted in a significant impact to the Company's access to liquidity to manage operations on an ongoing basis. Additionally the director has provided assurance that they will continue to support the company to enable it to meet its liabilities as they fall due.On the basis, the accounts have been prepared on going concern basis.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2021
Number
Average number of persons employed by the company 3
3 Creditors: amounts falling due within one year 2021
£
Bank loans and overdrafts 997
Other creditors -
997
4 Other information
AVIS PHARMALABS EXIM PRIVATE LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
9, Lassell Gardens
Maidenhead
England
SL6 8ND
AVIS PHARMALABS EXIM PRIVATE LIMITED 13079984 false 2020-12-14 2021-11-30 2021-11-30 VT Final Accounts April 2021 V. PUROHIT No description of principal activity 13079984 2020-12-14 2021-11-30 13079984 bus:PrivateLimitedCompanyLtd 2020-12-14 2021-11-30 13079984 bus:AuditExemptWithAccountantsReport 2020-12-14 2021-11-30 13079984 bus:Director40 2020-12-14 2021-11-30 13079984 2 2020-12-14 2021-11-30 13079984 countries:England 2020-12-14 2021-11-30 13079984 bus:FRS102 2020-12-14 2021-11-30 13079984 bus:FullAccounts 2020-12-14 2021-11-30 13079984 2021-11-30 13079984 core:WithinOneYear 2021-11-30 13079984 core:SharePremium 2021-11-30 13079984 core:RetainedEarningsAccumulatedLosses 2021-11-30 13079984 2020-12-13 iso4217:GBP xbrli:pure